Intervention Study on Digital Health Management

Tongji University

Status: Not yet enrolling

Conditions: Hypertension; Hyperlipidemia

Treatments: Other: Bracelet, assistant, APP: the "golden triangle" of smart life

Study type: Interventional

Funder types: Other

Identifiers

NCT06949306

NSS_3.0

Details and patient eligibility

About

The aim of this study is to construct a digital precision intervention system for cardiometabolism disorders based on the characteristics of the Chinese population, focusing on the core components of metabolic syndrome such as hypertension, hyperglycemia, and obesity. Through dynamic monitoring of wearable devices, the individualized risk factors (including genetic predisposition, lifestyle, and psychological factors) of metabolic disorders were systematically analyzed, and dynamic intervention strategies were formulated accordingly. The closed-loop management of "monitor-feedback-optimization" based on the digital platform will provide patients with one-stop metabolic risk assessment and panoramic health management plan, realizing a paradigm shift from "generalized intervention" to "precise regulation". By reducing the abnormal fluctuations of key metabolic indicators such as blood pressure, blood glucose, and blood lipids, the risk of cardiovascular events will eventually be reduced, the long-term quality of life of patients will be improved, and a practical path of "digital therapy" can be promoted for the prevention and control of chronic diseases in China

Enrollment: 300 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:1. Age 18-65 years old; 2. Meet one of the following three conditions:

1. Diastolic hypertension (systolic blood pressure < 140 MMHG and diastolic blood pressure ≥90mmHg)
2. Glycosylated hemoglobin (6.0-6.5)
3. Obesity (BMI≥28kg/m²)
4. Mild hyperlipemia: total cholesterol (TC) ≥5.2 mmol/L and < 6.2 mmol/L, or low-density lipoprotein cholesterol (LDL-C) ≥3.4 mmol/L and < 4.1 mmol/L 3. Antihypertensive or lipid-lowering medications have not been started 4. Use a smartphone and volunteer

Exclusion Criteria:

1. Complicated with chronic liver and kidney disease, coronary heart disease, heart failure and severe valvular disease
2. Previous cardiovascular and cerebrovascular events
3. Diastolic blood pressure ≥99mmHg
4. Glycated hemoglobin ≥6.5
5. Other life expectancy such as cancer is less than 5 years
6. Participate in other clinical trials

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

300 participants in 1 patient group

Cardiovascular digital management group

Experimental group

Description:

Participants used a bracelet and an APP assistant for lifestyle interventions

Treatment:

Other: Bracelet, assistant, APP: the "golden triangle" of smart life